Skip to main content
SpringerLink
Log in

Sandostatin® in the Treatment of Gastroenteropancreatic Endocrine Tumors

Consensus Round Table, Scottsdale (Arizona), March 22, 1987

  • Conference proceedings
  • © 1989

Overview

Editors:
  1. T. M. O’Dorisio

    1. College of Medicine, Department of Endocrinology, The Ohio State University, Columbus, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (16 papers)

  1. Front Matter

    Pages I-VIII
    Download chapter PDF

  2. Prologue

    • T. M. O’Dorisio
    Pages 1-2

  3. Chemical Structure — Pharmacological Profile of Sandostatin®

    • J. Pless
    Pages 3-13

  4. Carcinoid Tumours and the Carcinoid Syndrome

    • H. F. Woods, N. D. S. Bax, J. A. C. Thorpe, J. A. R. Smith
    Pages 15-22

  5. Tumors of the Gastroenteropancreatic Axis

    • T. S. Gaginella, T. M. O’Dorisio, H. S. Mekhjian, M. S. O’Dorisio, E. A. Woltering
    Pages 23-38

  6. The Use of Sandostatin® in Insulinomas. The Relation Between In Vivo Responses, the Presence of Somatostatin Receptors and the Development of Tachyphylaxis

    • S. W. J. Lamberts, J.-C. Reubi
    Pages 39-42

  7. Sandostatin®: Assay and Efficacy in VIPoma and Insulinoma

    • T. M. O’Dorisio, T. S. Gaginella, M. S. O’Dorisio, R. W. Meleca, D. A. Wray, K. Osei
    Pages 43-48

  8. Sandostatin® in Digestive Endocrine Tumors

    • J. A. Chayvialle, J. C. Souquet, G. Sassolas, C. Partensky
    Pages 49-52

  9. VIPoma, Gastrinoma and Glucagonoma

    • G. J. Krejs
    Pages 53-57

  10. Rebound Effect and Escape of Diarrhea Inhibition Using Sandostatin® in VIPoma Patients

    • K. Gyr, A. Koelz, M. Kraenzlin, C. Beglinger, V. Meier, S. R. Bloom
    Pages 59-60

  11. Long-Term Treatment of VIPoma and Glucagonoma with Sandostatin®

    • G. Williams, S. R. Bloom
    Pages 61-64

  12. Therapy of the Malignant Carcinoid Syndrome and Metastatic Islet Cell Carcinoma

    • L. K. Kvols
    Pages 65-82

  13. Sandostatin® in the Treatment of Advanced Malignancies

    • U. Sagman, S. Fine
    Pages 83-87

  14. Treatment of Malignant Neuroendocrine Gut and Pancreatic Tumors with Sandostatin®

    • K. Öberg, B. Eriksson, I. Norheim
    Pages 89-92

  15. Sandostatin® and Gastroenteropancreatic Endocrine Tumors — Therapeutic Characteristics

    • M. J. Dunne, R. Elton, T. Fletcher, P. Hofker, J. Shui
    Pages 93-113

  16. Consensus

    • T. M. O’Dorisio
    Pages 115-117

  17. Future Directions

    • T. M. O’Dorisio
    Pages 119-120

  18. Back Matter

    Pages 121-146
    Download chapter PDF
Back to top

Keywords

About this book

The secretion of bioactive products by tumors of the gastroenteropancreatic system results in the development of watery diarrhea that can lead to death in a very short period if not brought under control. Even if the consequences are less dramatic, the patients' ability to lead a normal daily life is seriously impaired, and they may become severely depressed. SandostatinR alleviates the condition by inhibiting peptide release, and its long duration of action makes it an effective and rational adjunct to therapy at all stages. Last year a consensus Round Table Meeting was held in Scottsdale, Arizona, to discuss the optimal use of SandostatinR in this indication. These guidelines offer the results of clinical research and the dosage recommendations arising from them, together with a critical summary of the points of view presented.

Editors and Affiliations

  • College of Medicine, Department of Endocrinology, The Ohio State University, Columbus, USA

    T. M. O’Dorisio

Bibliographic Information

  • Book Title: Sandostatin® in the Treatment of Gastroenteropancreatic Endocrine Tumors

  • Book Subtitle: Consensus Round Table, Scottsdale (Arizona), March 22, 1987

  • Editors: T. M. O’Dorisio

  • DOI: https://doi.org/10.1007/978-3-642-61328-9

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Verlag, Berlin Heidelberg 1989

  • Softcover ISBN: 978-3-642-64794-9Published: 12 October 2011

  • eBook ISBN: 978-3-642-61328-9Published: 06 December 2012

  • Edition Number: 1

  • Number of Pages: VIII, 146

  • Topics: Hepatology, Gastroenterology, Endocrinology, General Practice / Family Medicine, Pharmacology/Toxicology, Pathology

Publish with us

Policies and ethics

Back to top

Search

Navigation